Mike Birch

COO at F2G

Mike is one of the original members of the F2G scientific staff and has been instrumental in the development of F2G’s core MycoBank® technology. Mike has over fifteen years of research experience in commercial and academic laboratories, predominantly working on Aspergillus and pathogenic fungi. Over this period he has developed a wide network of contacts in the fungal research community. His research interests include molecular epidemiology, fungal pathogenesis and intracellular signalling.


Org chart


Teams


Offices

This person is not in any offices


F2G

1 followers

F2G is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening invasive fungal infections.


Industries

Employees

51-200

Links